# A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine

> **NCT03638011** · PHASE4 · TERMINATED · sponsor: **Maimonides Medical Center** · enrollment: 71 (actual)

## Conditions studied

- Caesarean Section

## Interventions

- **DRUG:** Exparel

## Key facts

- **NCT ID:** NCT03638011
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-25
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 71 (ACTUAL)
- **Why stopped:** Standard of Care changed due to COVID-19 and thus had to stop the study.
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03638011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03638011, "A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03638011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*